BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 25270728)

  • 1. Impact of isoniazid resistance on virulence of global and south Indian clinical isolates of Mycobacterium tuberculosis.
    Ameeruddin NU; Luke Elizabeth H
    Tuberculosis (Edinb); 2014 Dec; 94(6):557-63. PubMed ID: 25270728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of interactions of clinical mutants of catalase-peroxidase (KatG) responsible for isoniazid resistance in Mycobacterium tuberculosis with derivatives of isoniazid.
    Unissa AN; Doss C GP; Kumar T; Swathi S; Lakshmi AR; Hanna LE
    J Glob Antimicrob Resist; 2017 Dec; 11():57-67. PubMed ID: 28743650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular characterization of INH-resistant Mycobacterium tuberculosis isolates by PCR-RFLP and multiplex-PCR in North India.
    Mathuria JP; Nath G; Samaria JK; Anupurba S
    Infect Genet Evol; 2009 Dec; 9(6):1352-5. PubMed ID: 19786122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of novel
    Valafar F; Ramirez-Busby SM; Torres J; Paul LV; Rodwell TC; Victor TC; Rodrigues C; Gler MT; Crudu V; Catanzaro T
    Int J Mycobacteriol; 2015 Mar; 4(Suppl 1):51-52. PubMed ID: 27695670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative study of enzymatic activities of new KatG mutants from low- and high-level isoniazid-resistant clinical isolates of Mycobacterium tuberculosis.
    Brossier F; Boudinet M; Jarlier V; Petrella S; Sougakoff W
    Tuberculosis (Edinb); 2016 Sep; 100():15-24. PubMed ID: 27553406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ethionamide cross- and co-resistance in children with isoniazid-resistant tuberculosis.
    Schaaf HS; Victor TC; Venter A; Brittle W; Jordaan AM; Hesseling AC; Marais BJ; van Helden PD; Donald PR
    Int J Tuberc Lung Dis; 2009 Nov; 13(11):1355-9. PubMed ID: 19861006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Detection of S315T mutation in the katg gene as a strategy for identification of isoniazid-resistant Mycobacterium tuberculosis in a reference laboratory].
    Romay Z; Arráiz N; Fuenmayor A; Ramírez C; Rojas L; París R
    Rev Chilena Infectol; 2012 Dec; 29(6):607-13. PubMed ID: 23412028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Downregulation of katG expression is associated with isoniazid resistance in Mycobacterium tuberculosis.
    Ando H; Kitao T; Miyoshi-Akiyama T; Kato S; Mori T; Kirikae T
    Mol Microbiol; 2011 Mar; 79(6):1615-28. PubMed ID: 21244531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variants of katG, inhA and nat genes are not associated with mutations in efflux pump genes (mmpL3 and mmpL7) in isoniazid-resistant clinical isolates of Mycobacterium tuberculosis from India.
    Unissa AN; Dusthackeer VNA; Kumar MP; Nagarajan P; Sukumar S; Kumari VI; Lakshmi AR; Hanna LE
    Tuberculosis (Edinb); 2017 Dec; 107():144-148. PubMed ID: 29050763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of katG mutations associated with high-level isoniazid resistance in Mycobacterium tuberculosis.
    Ando H; Kondo Y; Suetake T; Toyota E; Kato S; Mori T; Kirikae T
    Antimicrob Agents Chemother; 2010 May; 54(5):1793-9. PubMed ID: 20211896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Defining of gene mutations and minimal inhibitory concentrations in isoniazid resistant Mycobacterium tuberculosis isolates].
    Yıldırım E; Uzun M
    Mikrobiyol Bul; 2017 Oct; 51(4):305-316. PubMed ID: 29153061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigation of Ser315 substitutions within katG gene in isoniazid-resistant clinical isolates of Mycobacterium tuberculosis from south India.
    Unissa AN; Selvakumar N; Narayanan S; Suganthi C; Hanna LE
    Biomed Res Int; 2015; 2015():257983. PubMed ID: 25699262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel katG mutations causing isoniazid resistance in clinical M. tuberculosis isolates.
    Torres JN; Paul LV; Rodwell TC; Victor TC; Amallraja AM; Elghraoui A; Goodmanson AP; Ramirez-Busby SM; Chawla A; Zadorozhny V; Streicher EM; Sirgel FA; Catanzaro D; Rodrigues C; Gler MT; Crudu V; Catanzaro A; Valafar F
    Emerg Microbes Infect; 2015 Jul; 4(7):e42. PubMed ID: 26251830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of katG Ser315 substitution and rpoB mutations in isoniazid-resistant Mycobacterium tuberculosis isolates from Brazil.
    Höfling CC; Pavan EM; Giampaglia CM; Ferrazoli L; Aily DC; de Albuquerque DM; Ramos MC
    Int J Tuberc Lung Dis; 2005 Jan; 9(1):87-93. PubMed ID: 15675556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Detection of KatG 315 gene mutation associated with isoniazid resistance in Mycobacterium tuberculosis by template-directed dye-terminator incorporation with fluorescence polarization detection technology].
    Wang Y; Zhang WH; Zhao JR; Luo M; Zhang ZX; Bai YJ; Yan XJ
    Zhonghua Jie He He Hu Xi Za Zhi; 2004 Mar; 27(3):179-82. PubMed ID: 15130329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isoniazid-resistance conferring mutations in Mycobacterium tuberculosis KatG: catalase, peroxidase, and INH-NADH adduct formation activities.
    Cade CE; Dlouhy AC; Medzihradszky KF; Salas-Castillo SP; Ghiladi RA
    Protein Sci; 2010 Mar; 19(3):458-74. PubMed ID: 20054829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of novel coupled mutations in the katG gene (His276Met, Gln295His and Ser315Thr) in a multidrug-resistant Mycobacterium tuberculosis strain from Chennai, India, and insight into the molecular mechanism of isoniazid resistance using structural bioinformatics approaches.
    Ramasubban G; Therese KL; Vetrivel U; Sivashanmugam M; Rajan P; Sridhar R; Madhavan HN; Meenakshi N
    Int J Antimicrob Agents; 2011 Apr; 37(4):368-72. PubMed ID: 21330112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can mycobacterial katG genetic changes in isoniazid-resistant tuberculosis influence human disease features?
    Escalante P; McKean-Cowdin R; Ramaswamy SV; Williams-Bouyer N; Teeter LD; Jones BE; Graviss EA
    Int J Tuberc Lung Dis; 2013 May; 17(5):644-51. PubMed ID: 23453008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significance of catalase-peroxidase (KatG) mutations in mediating isoniazid resistance in clinical strains of Mycobacterium tuberculosis.
    Unissa AN; Doss C GP; Kumar T; Sukumar S; Lakshmi AR; Hanna LE
    J Glob Antimicrob Resist; 2018 Dec; 15():111-120. PubMed ID: 29990547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overview on mechanisms of isoniazid action and resistance in Mycobacterium tuberculosis.
    Unissa AN; Subbian S; Hanna LE; Selvakumar N
    Infect Genet Evol; 2016 Nov; 45():474-492. PubMed ID: 27612406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.